| Literature DB >> 26404826 |
Daniel H Geschwind1, Jonathan Flint2.
Abstract
Large-scale genomic investigations have just begun to illuminate the molecular genetic contributions to major psychiatric illnesses, ranging from small-effect-size common variants to larger-effect-size rare mutations. The findings provide causal anchors from which to understand their neurobiological basis. Although these studies represent enormous success, they highlight major challenges reflected in the heterogeneity and polygenicity of all of these conditions and the difficulty of connecting multiple levels of molecular, cellular, and circuit functions to complex human behavior. Nevertheless, these advances place us on the threshold of a new frontier in the pathophysiological understanding, diagnosis, and treatment of psychiatric disease.Entities:
Mesh:
Year: 2015 PMID: 26404826 PMCID: PMC4694563 DOI: 10.1126/science.aaa8954
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728